Open AccessGnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study
Author(s) -
Peter Humaidan,
H.E. Bredkjær,
Leif Bungum,
M. Bungum,
Marie Louise Grøndahl,
Lars Westergaard,
Claus Yding Andersen
Publication year - 2005
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/deh765
Subject(s) - buserelin , ovulation induction , agonist , ovulation , medicine , randomized controlled trial , hormone antagonist , gynecology , antagonist , andrology , hormone , receptor
We aimed to determine the efficacy of ovarian hyperstimulation protocols employing a GnRH antagonist to prevent a premature LH rise allowing final oocyte maturation and ovulation to be induced by a single bolus of either a GnRH agonist or hCG.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom